Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
OKYO Pharma Limited Sponsored ADR (OKYO) had Stock-Based Compensation of $0.55M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$4.64M |
|
$0.00M |
|
$0.00M |
|
$4.64M |
|
$8.06M |
|
-- |
|
-- |
|
$8.06M |
|
$-3.42M |
|
$-3.42M |
|
$-3.42M |
|
38.45M |
|
| Cash Flow Statement Financials | |
$-1.53M |
|
-- |
|
$4.32M |
|
$1.56M |
|
$4.22M |
|
$2.66M |
|
|
Stock-Based Compensation |
$0.55M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|